The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
Correction: Interdisciplinary collaboration in the treatment of alcohol use disorders in a general hospital department: a mixed-method study
Background Interdisciplinary collaborations (i.e., where various disciplines work coordinated and interdependently toward shared goals) are stated to yield higher team effectiveness than multidisciplinary approaches (i.e., where various...
Understanding injecting drug use in Afghanistan: A scoping review
Background Several reports have described a growing prevalence of illicit drug use in Afghanistan, with recognition of a recent shift from traditional modes of consumption involving inhalation and oral ingestion to injecting drug use...
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
Introduction and aims There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary...
Disruptions to U.S. local public health’s role in population-based substance use prevention and response during COVID-19
Background The COVID-19 emergency has tested the public health, medical, and public safety infrastructure of the United States (U.S.) in unprecedented ways. As the focal point for public health in their communities, local health departments...
Mortality and life-years lost following subsequent physical comorbidity in people with pre-existing substance use disorders: a national registry-based retrospective cohort study of hospitalised individuals in Czechia
Summary Background Substance use disorders constitute a major global public health problem, attributable largely to their subsequent comorbidity with other health conditions. This study aimed to investigate the risk of all-cause death and...
Patterns of Health Care Use 5 Years After an Intervention Linking Patients in Addiction Treatment With a Primary Care Practitioner
Abstract Importance Substance use disorders are associated with high rates of emergency department (ED) use and challenges engaging with primary care services. Objective To examine 5-year health care engagement and utilization outcomes for...
INL DDR Partners Call - Quality Assurance
This month on November 9th, 2022, the International Narcotics and Law Enforcement Affairs (INL) DDR Partners meeting offered a discussion on quality assurance and included two presentations: Building Quality Improvement for SUD Treatment...
"The Situation of mental health, violence against Women in the context of the post-COVID19 pandemic" progress, challenges and challenges
ISSUP Peru wants to invite you to its next Webinar.
World AIDS Day 2022 Event: Challenges and Perspectives from SUD Treatment Practice
In acknowledgement of World AIDS Day, ISSUP Italy would like to invite you to attend their upcoming Webinar. First Presentation: The Post COVID-19 AIDS Challenges The characteristics of HIV infection and how they have evolved over the years...
ADDICTUS 2022, 4th National Forum on Pathological Addictions
ADDICTUS 2022 IV° NATIONAL FORUM ON PATHOLOGICAL ADDICTIONS Riva del Garda Congress Centre (TN) 2 - 4 December 2022 Scientific coordinators: Fabio Lugoboni, Anna Franceschini, Stefano Canali FRIDAY 2.12.22 Neurodevelopmental disorders (DNS)...